Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis - C 2016 NIDA 4R25DA013582-15 Clinical Addiction Research and Education Program SAMET, JEFFREY BOSTON MEDICAL CENTER MA $349,453
Hepatitis - C 2016 NIAID 4R01AI095097-05 HIV co-infection and HCV-induced liver fibrosis in vivo SU, LISHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $370,000
Hepatitis - C 2016 NIAID 5R01AI110577-02 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $450,062
Hepatitis - C 2016 NIDA 1DP2DA040244-01 Reaching the hardest of the hard-to-reach SOLOMON, SUNIL JOHNS HOPKINS UNIVERSITY MD $2,430,000
Hepatitis - C 2016 NIAID 5R01AI114748-02 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis - C 2016 NIAID 5R03AI115171-03 Exploring HCV infection in engineered cultures of iPSC-derived human liver cells KHETANI, SALMAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $79,921
Hepatitis - C 2016 NIAID 4R01AI103440-04 A molecular basis for control of T cell memory HEDRICK, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $465,000
Hepatitis - C 2016 NIDA 4R01DA035146-04 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $608,005
Hepatitis - C 2016 NIDA 4P30DA011041-19 5121 Infectious Diseases and Biomedical Core PERLMAN, DAVID NEW YORK UNIVERSITY NY $102,568
Hepatitis - C 2016 NIAID 5R37AI047365-17 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Hepatitis - C 2016 NIAID 4UM1AI069536-10 HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) SPECTOR, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $2,074,220
Hepatitis - C 2016 NIAID 4K08AI102761-04 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $185,121
Hepatitis - C 2016 NIAID 5R01AI108765-03 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $435,000
Hepatitis - C 2016 NIAAA 5P50AA011999-18 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $203,571
Hepatitis - C 2016 NIAID 4R01AI070101-10 Mechanisms of hepatitis C virus persistence GRAKOUI, ARASH EMORY UNIVERSITY GA $440,000
Hepatitis - C 2016 NIAID 4R01AI096882-05 Persistent hepatitis C virus replication and T cell immunity in pregnancy WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $584,545
Hepatitis - C 2016 NIAID 5R01AI099506-03 Modulation of internal ribosome entry by ribosomal protein RPS25 SARNOW, PETER STANFORD UNIVERSITY CA $577,666
Hepatitis - C 2016 NIAID 5U01AI115714-02 Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant STOCK, PETER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $604,473
Hepatitis - C 2016 NIDDK 5R01DK099055-03 Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease PARK, IN-WOO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $334,839
Hepatitis - C 2016 NIDDK 5R01DK077704-08 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $337,125
Hepatitis - C 2016 NIDA 5R34DA038530-02 A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $319,837
Hepatitis - C 2016 NIDA 4K23DA031612-05 Supporting Health in Drug Treatment Court for Women with HIV or Hepatitis C MORSE, DIANE UNIVERSITY OF ROCHESTER NY $171,871
Hepatitis - C 2016 NIAID 4R01AI105035-04 CD4+ T Cells in Acute Versus Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $435,000
Hepatitis - C 2016 NIDDK 5F30DK104562-02 Lipid-mediated control of immune responses in hepatitis C virus infection NARAYANAN, SOWMYA UNIVERSITY OF VIRGINIA VA $48,576
Hepatitis - C 2016 NIAID 5R01AI111970-03 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,120,190
Hepatitis - C 2016 NIAID 4R01AI097318-06 Underlying Mechanisms of ApoE in HCV Infection and Assembly LUO, GUANGXIANG UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $367,500
Hepatitis - C 2016 NIAID 5R44AI106215-03 Development of a Microfluidic Point-of-Care HCV Viral Load Assay FERNANDEZ-SUAREZ, MARTA DAKTARI DIAGNOSTICS, INC. MA $597,342
Hepatitis - C 2016 NIAID 5R21AI118337-02 Host and viral determinants of hepatitis C virus macaque infection EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $263,629
Hepatitis - C 2016 NIDA 4R01DA015612-14 Making Better Decisions: Policy Modeling for AIDS and Drug Abuse OWENS, DOUGLAS STANFORD UNIVERSITY CA $623,455
Hepatitis - C 2016 NIAID 1K08AI121348-01 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $184,637
Hepatitis - C 2016 NIAAA 5K23AA023753-02 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $186,192
Hepatitis - C 2016 NCI 5R01CA190776-02 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $636,299
Hepatitis - C 2016 NIDA 5R01DA027379-05 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $485,416
Hepatitis - C 2016 NIAID 5R01AI106005-03 Dissecting virus neutralizing determinants to guide HCV vaccine development LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $450,000
Hepatitis - C 2016 NICHD 5R01HD075549-03 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $318,609
Hepatitis - C 2016 NIDA 4R01DA012568-18 INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,250,722
Hepatitis - C 2016 NIDDK 4K23DK090209-05 Gender and hormonal influences on liver fibrosis after transplant for hepatitis C FORDE, KIMBERLY UNIVERSITY OF PENNSYLVANIA PA $182,110
Hepatitis - C 2016 NIGMS 4P41GM103314-43 National Resource for Mass Spectrom of Biological Macromolecules CHAIT, BRIAN ROCKEFELLER UNIVERSITY NY $1,619,191
Hepatitis - C 2016 NHLBI 1R01HL127174-01A1 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $504,478
Hepatitis - C 2016 NIDA 5R01DA016065-13 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $700,614
Hepatitis - C 2016 NIAAA 4R01AA012863-16 Mechanisms of Liver Injury by Hepatitis C and Alcohol WEINMAN, STEVEN UNIVERSITY OF KANSAS MEDICAL CENTER KS $516,577
Hepatitis - C 2016 NIDA 5K01DA036452-03 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Hepatitis - C 2016 NIAID 1R01AI116868-01A1 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $787,985
Hepatitis - C 2016 NIDDK 4R01DK097374-04 Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus TAI, ANDREW UNIVERSITY OF MICHIGAN MI $338,213
Hepatitis - C 2016 NIAID 2R01AI078881-06 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $544,109
Hepatitis - C 2016 NIAID 5R01AI110358-02 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $387,500
Hepatitis - C 2016 NIDA 5R01DA039072-02 Life Course Investigation of People Who Inject Drugs BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $559,014
Hepatitis - C 2016 NIDA 4R01DA022177-10 Opioids, HIV/HCV and host cell innate immunity HO, WENZHE TEMPLE UNIV OF THE COMMONWEALTH PA $235,966
Hepatitis - C 2016 NIAID 4R01AI099245-05 The PIP2-virus interface and PI 4-kinase: novel biology and validation targets GLENN, JEFFREY STANFORD UNIVERSITY CA $996,649
Hepatitis - C 2016 NIAID 5U19AI111825-03 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $644,149
Hepatitis - C 2016 NIDA 5R01DA025885-08 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $545,835
Hepatitis - C 2016 NIMH 4K01MH097847-04 An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C RETHORST, CHAD UT SOUTHWESTERN MEDICAL CENTER TX $148,640
Hepatitis - C 2016 NIDA 5K24DA035684-03 Treatment outcomes and comorbidity in HIV-infected IDU LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $167,171
Hepatitis - C 2016 NCI 4R01CA164029-05 Murine Model of HCV-Associated Human Liver Cancer LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $470,695
Hepatitis - C 2016 NIAID 5R01AI085087-06 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $387,500
Hepatitis - C 2016 NIAID 5U19AI109662-03 7133 Haploid genetic screen to identify host genes required for RNA virruses GLENN, JEFFREY STANFORD UNIVERSITY CA $424,601
Hepatitis - C 2016 NIAID 5U19AI109662-03 7134 Computation and Repurposing to identfy antivirals directed against dominant PANDE, VIJAY STANFORD UNIVERSITY CA $742,632
Hepatitis - C 2016 NIAID 5U19AI109662-03 7135 Novel Interferons and small molecule enhancers of the interferon pathway GARCIA, KENAN STANFORD UNIVERSITY CA $501,177
Hepatitis - C 2016 NIDA 4K24DA034621-05 Patient Oriented Research in Hepatitis C-infected Injection Drug Users SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $118,638
Hepatitis - C 2016 NIDDK 2R01DK081817-06A1 HCV infection, cross-talk among liver cells, and liver disease progression RAY, RATNA SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis - C 2016 NIAID 5R01AI097552-03 Role of Lipid Droplets in Hepatitis C Virus Infection OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $477,500
Hepatitis - C 2016 NIDA 4R01DA033777-05 Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs MARKOWITZ, MARTIN AARON DIAMOND AIDS RESEARCH CENTER NY $920,449
Hepatitis - C 2016 NIDA 4R01DA034637-04 Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics HAGAN, HOLLY NEW YORK UNIVERSITY NY $654,934
Hepatitis - C 2016 NIAID 4R01AI072613-10 Identification and characterization of cellular factors involved in HCV entry RICE, CHARLES ROCKEFELLER UNIVERSITY NY $546,673
Hepatitis - C 2016 NCI 5R21CA188472-02 Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma RAY, RATNA SAINT LOUIS UNIVERSITY MO $177,066
Hepatitis - C 2016 NIDDK 5R01DK102883-02 HEPATOCYTE REMODELING BY HEPATITIS C VIRUS RANDALL, GLENN UNIVERSITY OF CHICAGO IL $350,489
Hepatitis - C 2016 NIAID 4R01AI099284-05 Hepatitis C antivirals: Mechanism of action, combination efficacy and resistance RICE, CHARLES ROCKEFELLER UNIVERSITY NY $735,361
Hepatitis - C 2016 NIAID 4R01AI052447-14 Gene Silencing as an Antiviral Defense in Animal Cells DING, SHOU-WEI UNIVERSITY OF CALIFORNIA RIVERSIDE CA $493,017
Hepatitis - C 2016 NIDA 5R25DA037190-03 The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIV BECKWITH, CURT MIRIAM HOSPITAL RI $249,169
Hepatitis - C 2016 NIDDK 5R01DK101773-02 Innate Defense Program against HCV SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis - C 2016 NIAID 5R03AI111047-02 A High throughput Reverse Genetics System for Hepatitis C Virus FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $75,750
Hepatitis - C 2016 NCI 5R01CA186566-02 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $657,227
Hepatitis - C 2016 NIGMS 4R01GM105414-04 Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV BLACKARD, JASON UNIVERSITY OF CINCINNATI OH $295,229
Hepatitis - C 2016 NIDA 5R21DA039345-02 Facilitating HCV Treatment through Tailored Prenatal Care for HCV Infected, Substance using Pregnant Women KRANS, ELIZABETH MAGEE-WOMEN'S RES INST AND FOUNDATION PA $194,133
Hepatitis - C 2016 NIAID 1R01AI116943-01A1 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $539,134
Hepatitis - C 2016 NCI 4R01CA089121-10 Hepatitis C Virus and Hepatocellular Carcinoma DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $237,038
Hepatitis - C 2016 NIGMS 4R01GM064803-12 Genome-Scale Analysis of RNA Virus Tertiary Structure WEEKS, KEVIN UNIV OF NORTH CAROLINA CHAPEL HILL NC $317,677
Hepatitis - C 2016 NIDA 4U01DA036267-04 MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) GORBACH, PAMINA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $1,539,723
Hepatitis - C 2016 NIDA 5R01DA036514-03 Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $708,767
Hepatitis - C 2016 OD 5R01OD011095-24 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $444,412
Hepatitis - C 2016 NIDA 1R41DA041246-01 Mobile Intervention Kit to Increase HIV/HCV Testing and Overdose Prevention Training ARONSON, IAN DIGITAL HEALTH EMPOWERMENT, INC. NY $152,762
Hepatitis - C 2016 NIAID 4R01AI069285-10 Role of TLR3 Signaling in Control of HCV LI, KUI UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $337,500
Hepatitis - C 2016 NIDA 4R01DA016078-15 The Progression of Hepatitis C Among IDUs with HIV BALAGOPAL, ASHWIN JOHNS HOPKINS UNIVERSITY MD $687,429
Hepatitis - C 2016 NINR 1F31NR016200-01 Nurse Case Management to Improve Hepatitis C Linkage to Care and Treatment in HIV Coinfection STARBIRD, LAURA JOHNS HOPKINS UNIVERSITY MD $36,091
Hepatitis - C 2016 NIDA 1R01DA041298-01 Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $594,712
Hepatitis - C 2016 NIAID 4R01AI079031-08 Understanding human neutralizing antibodies to hepatitis C virus LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $556,005
Hepatitis - C 2016 NIAID 5U19AI082630-08 7590 Restoration of Innate Immunity with Viral Cure CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $447,514
Hepatitis - C 2016 NIAID 5U19AI082630-08 7591 Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $466,414
Hepatitis - C 2016 NIAID 5U19AI082630-08 7592 Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy HAINING, WILLIAM DANA-FARBER CANCER INST MA $533,673
Hepatitis - C 2016 NIAID 5U19AI082630-08 7593 Induction and Recovery of T Cells after Cure of Chronic Viral Infection KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $321,776
Hepatitis - C 2016 NIAID 5U19AI082630-08 7594 Administrative Core CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $148,732
Hepatitis - C 2016 NIAID 5U19AI082630-08 7595 Pilot/Feasibility Studies Program CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $64,620
Hepatitis - C 2016 NIAID 5U19AI082630-08 7596 Tissue and Clinical Core KIM, ARTHUR MASSACHUSETTS GENERAL HOSPITAL MA $214,234
Hepatitis - C 2016 NIAID 5U19AI082630-08 7597 Virology Core ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $80,148
Hepatitis - C 2016 NIDA 5R37DA013806-17 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $726,240
Hepatitis - C 2016 NHLBI 5R01HL126543-04 Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms KAPLAN, ROBERT ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $841,929
Hepatitis - C 2016 NIDA 4U01DA033336-04 Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry LEE, JOSHUA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $677,777
Hepatitis - C 2016 NIGMS 4R01GM081346-08 Structural basis of protein synthesis by the hepatitis C virus IRES RNA KIEFT, JEFFREY UNIVERSITY OF COLORADO DENVER CO $292,989
Hepatitis - C 2016 NIMH 5R21MH106904-02 Neurobiology of cytokine effects on CNS glutamate in IFN-alpha-induced depression FELGER, JENNIFER EMORY UNIVERSITY GA $195,000
Hepatitis - C 2016 NCI 5F32CA192633-02 Disruption of the Host DNA Damage Response by Hepatitis C Virus MITCHELL, JONATHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $32,484
Hepatitis - C 2016 NIDDK 4K01DK095031-06 Interactions between type I and III interferon during resolution of HCV infection SCHOGGINS, JOHN UT SOUTHWESTERN MEDICAL CENTER TX $102,087
Hepatitis - C 2016 NIAID 1R01AI123365-01 Structure and function of Hepacivirus envelope glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $625,625
Hepatitis - C 2016 NIAAA 4R01AA021133-04 RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse PROESCHOLD-BELL, RAE JEAN DUKE UNIVERSITY NC $690,304
Hepatitis - C 2016 NIMH 4R01MH085538-07 Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients PULLIAM, LYNN NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $508,271
Hepatitis - C 2016 NIDA 5R21DA038304-02 Digital Health Technology Use Among Methadone Maintenance Patients MASSON, CARMEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $184,934
Hepatitis - C 2016 NIAID 5K23AI108355-02 Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients VENUTO, CHARLES UNIVERSITY OF ROCHESTER NY $140,233
Hepatitis - C 2016 NIDA 1R34DA041465-01 Facilitating treatment entry and family planning in substance-using NICU mothers STOTTS, ANGELA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $231,000
Hepatitis - C 2016 NIAID 5R21AI115476-02 T cell responses at the site of infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $217,500
Hepatitis - C 2016 NIAID 5R21AI119530-02 Dissecting Dengue Virus Permissiveness using a Stem Cell Differentiation System TANG, HENGLI FLORIDA STATE UNIVERSITY FL $221,453
Hepatitis - C 2016 NIAID 5R21AI120113-02 Bacterial effectors as probes to study (+) RNA virus-host cell biology LINDENBACH, BRETT YALE UNIVERSITY CT $208,125
Hepatitis - C 2016 NIDA 4R01DA033866-05 Brief intervention for drug-using rural women at high-risk for HIV/HCV TINDALL, MICHELE UNIVERSITY OF KENTUCKY KY $514,704
Hepatitis - C 2016 NIAID 5R01AI085051-07 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $523,252
Hepatitis - C 2016 NIAID 1R21AI124100-01 Defining novel Riplet-activated antiviral innate immune signaling pathways HORNER, STACY DUKE UNIVERSITY NC $238,500
Hepatitis - C 2016 NIAID 4K24AI108516-04 HIV, HCV, and gender effects on Liver, Bone, and Vascular Health TIEN, PHYLLIS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $133,956
Hepatitis - C 2016 NIAID 5R21AI118686-02 Structure-based immunogen design for hepatitis C virus ZHU, JIANG SCRIPPS RESEARCH INSTITUTE CA $240,625
Hepatitis - C 2016 NIDA 5R01DA037117-03 Injection Risk Networks in Rural Puerto Rico DOMBROWSKI, KIRK UNIVERSITY OF NEBRASKA LINCOLN NE $633,559
Hepatitis - C 2016 NIAID 4R01AI098126-05 Role of HCV in aberrant APC activation/function HAHN, YOUNG UNIVERSITY OF VIRGINIA VA $392,100
Hepatitis - C 2016 NIAID 4R01AI108403-04 Antibody-Mediated Suppression of Antiviral Inflammasome Activation COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $442,767
Hepatitis - C 2016 NIDA 5K24DA037034-03 Mentoring and Empowerment in the Context of HIV Care for At-Risk Populations JOHNSON, MALLORY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $183,707
Hepatitis - C 2016 NIAID 1R21AI119499-01A1 Hepatitis C virus polyprotein processing efficiency regulates infectious virus production TELLINGHUISEN, TIMOTHY SCRIPPS FLORIDA FL $288,000
Hepatitis - C 2016 NIAID 4R01AI107301-04 Genetic viral and host adaptations to breach species barriers of HCV PLOSS, ALEXANDER PRINCETON UNIVERSITY NJ $402,500
Hepatitis - C 2016 NIDA 5R01DA034086-06 Intensive Models of HCV Care for Injection Drug Users LITWIN, ALAIN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $690,269
Hepatitis - C 2016 NIAID 1U19AI123862-01 6261 Admin Core FOUNG, STEVEN STANFORD UNIVERSITY CA $90,196
Hepatitis - C 2016 NIAID 1U19AI123862-01 6262 Humoral immunity against hepatitis C in protected subjects FOUNG, STEVEN STANFORD UNIVERSITY CA $329,719
Hepatitis - C 2016 NIAID 1U19AI123862-01 6263 Project 2 - France BAUMERT, THOMAS NIH $278,031
Hepatitis - C 2016 NIAID 1U19AI123861-01 6292 Administrative Core LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $278,641
Hepatitis - C 2016 NIAID 1U19AI123861-01 6293 Antibody responses to HCV vaccine antigens in infection and vaccination LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $389,961
Hepatitis - C 2016 NIAID 1U19AI123861-01 6294 Novel HCV vaccine antigens targeting conserved neutralizing epitopes ZHU, JIANG SCRIPPS RESEARCH INSTITUTE CA $289,740
Hepatitis - C 2016 NIAID 2U19AI088791-06 6463 Administrative Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $28,827
Hepatitis - C 2016 NIAID 2U19AI088791-06 6464 Scientific Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $258,610
Hepatitis - C 2016 NIAID 2U19AI088791-06 6465 Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans RAY, STUART JOHNS HOPKINS UNIVERSITY MD $122,281
Hepatitis - C 2016 NIAID 2U19AI088791-06 6466 Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $147,701
Hepatitis - C 2016 NIAID 2U19AI088791-06 6467 Project 3: To define the genetic identity of infecting, superinfecting, and reinfecting strains of HCV and the dynamics of virus elimination, replacement or persistence SHAW, GEORGE UNIVERSITY OF PENNSYLVANIA PA $234,059
Hepatitis - C 2016 NIDA 5R01DA040449-02 Impact on opioid use of bundling medication-assisted treatment with mHealth GUSTAFSON, DAVID UNIVERSITY OF WISCONSIN-MADISON WI $698,163
Hepatitis - C 2016 NIAID 5R21AI115207-02 Mechanism of Action of Hepatitis C Virus NS5A Inhibitors MCGIVERN, DAVID UNIV OF NORTH CAROLINA CHAPEL HILL NC $190,000
Hepatitis - C 2016 NIDDK 4K24DK078154-10 Epidemiology and Outcomes of Digestive and Liver Diseases: A Mentoring Program EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $98,954
Hepatitis - C 2016 NIDA 5K01DA037802-03 Understanding the interpersonal context of HIV/HCV risk within injecting dyads MORRIS, MEGHAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $182,596
Hepatitis - C 2016 NIGMS 5U01GM110749-04 Modeling Epidemic Infectious Diseases Using Sequence Analysis POND, SERGEI TEMPLE UNIV OF THE COMMONWEALTH PA $555,642
Hepatitis - C 2016 NIAID 4R01AI103106-04 IL-28B genotype and HCV treatment clearance DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $376,250
Hepatitis - C 2016 NIAID 5R21AI117213-02 Impact of species-specific host responses on restriction of hepatotropic viruses PLOSS, ALEXANDER PRINCETON UNIVERSITY NJ $248,625
Hepatitis - C 2016 NIAID 1R01AI118916-01A1 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $513,411
Hepatitis - C 2016 NIDDK 1R01DK106244-01A1 Hepatitus C virus-induced inflammasome and lipid metabolism WARIS, GULAM ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $351,000
Hepatitis - C 2016 NIDDK 2R01DK088787-06A1 HCV Entry: Mechanisms and Therapeutics WANG, TONY SRI INTERNATIONAL CA $609,843
Hepatitis - C 2016 NIAID 2R01AI071068-11 Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases KAY, MARK STANFORD UNIVERSITY CA $481,343
Hepatitis - C 2016 NIDA 5R01DA040499-02 Antiviral pharmacology and adherence in drug users KISER, JENNIFER UNIVERSITY OF COLORADO DENVER CO $521,849
Hepatitis - C 2016 NIAID 5R01AI105007-03 Cyclophilins and the IFN Response GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $401,255
Hepatitis - C 2016 NIDA 5R34DA039333-02 Hepatitis C Treatment As Prevention Pilot Study with Ledipasvir-Sofosbuvir Among People Actively Injecting Drugs (TasP-C Pilot) COFFIN, PHILLIP PUBLIC HEALTH FOUNDATION ENTERPRISES CA $193,031
Hepatitis - C 2016 NIAAA 5R01AA023726-03 Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons STEIN, MICHAEL BUTLER HOSPITAL (PROVIDENCE, RI) RI $497,195
Hepatitis - C 2016 NCI 5R21CA191903-03 Determining the function of IRF5 tumor suppressor in HCV pathogenesis BARNES, BETSY FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH NY $183,244
Hepatitis - C 2016 NIDA 5R01DA026770-07 Early-Stage Chronic Kidney Disease in HIV-infected Individuals LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $618,943
Hepatitis - C 2016 NIAAA 4K24AA022523-04 Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis KHALILI, MANDANA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $180,062
Hepatitis - C 2016 NIDA 5R13DA040427-02 Dissemination and implementation of evidenced based treatments for substance abuse disorders and HIV for justice involved populations FERGUSON, WARREN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $25,511
Hepatitis - C 2016 NIDA 5R01DA040488-02 RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression LATKIN, CARL JOHNS HOPKINS UNIVERSITY MD $666,924
Hepatitis - C 2016 NIDA 5P30DA040500-02 6227 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Admin Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $225,696
Hepatitis - C 2016 NIDA 5P30DA040500-02 6228 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Methodology Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $257,211
Hepatitis - C 2016 NIDA 5P30DA040500-02 6229 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) LINAS, BENJAMIN BOSTON MEDICAL CENTER MA $249,656
Hepatitis - C 2016 NIDA 5P30DA040500-02 6230 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Dissemination Core) MEISEL, ZACHARY UNIVERSITY OF PENNSYLVANIA PA $305,547
Hepatitis - C 2016 NIDA 5P30DA040500-02 6231 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Pilot Training Core) ADEN, BRANDON WEILL MEDICAL COLL OF CORNELL UNIV NY $88,922
Hepatitis - C 2016 NIAID 1R03AI119602-01A1 Identification of cellular factors that mediate HCV cell-to-cell spread UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $75,500
Hepatitis - C 2016 NHGRI 1RM1HG009038-01 Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease GELLER, GAIL JOHNS HOPKINS UNIVERSITY MD $1,015,999
Hepatitis - C 2016 NCI 2U01AI069918-11 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $260,000
Hepatitis - C 2016 NIAID 2U01AI069918-11 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $2,340,000
Hepatitis - C 2016 NIDA 2U01AI069918-11 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $100,000
Hepatitis - C 2016 NIDDK 4R01DK095125-05 Hepatitis C virus polarized cell entry pathways EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $365,343
Hepatitis - C 2016 NIGMS 4R01GM066978-12 Structure, Dynamics, and Functions of the Viroporins Vpu from HIV and p7 from HCV OPELLA, STANLEY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $302,887
Hepatitis - C 2016 NIDA 1R01DA041736-01 Individual, Network and Spatial Drivers of HIV and HCV among PWID in India SOLOMON, SUNIL JOHNS HOPKINS UNIVERSITY MD $897,280
Hepatitis - C 2016 NIDA 5UG1DA015815-15 Western States Node of the National Drug Abuse Treatment Clinical Trials Network SORENSEN, JAMES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $716,901
Hepatitis - C 2016 NIDA 5R01DA039775-02 Impact of HCV Therapy on CNS Outcomes BHARTI, AJAY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $753,645
Hepatitis - C 2016 NIAAA 4R37AA014372-14 HCV, Alcohol and Host Defense SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $367,110
Hepatitis - C 2016 NIAID 2R01AI095690-06 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Hepatitis - C 2016 NIDA 5R01DA013324-18 HIV and Hepatitis C Pathogenesis & The Human Genome THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $739,406
Hepatitis - C 2016 NIGMS 1F31GM119345-01 Structure-based design of robust cross-genotypic NS3/4A protease inhibitors that avoid resistance MATTHEW, ASHLEY UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $32,692
Hepatitis - C 2016 NCCIH 5R01AT007318-06 Natural Product HCV Drugs from Rare Plant-Microbe Interactions HAMANN, MARK MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $378,953
Hepatitis - C 2016 NIAID 2R01AI087925-06 Molecular determinants of hepatitis C virus assembly LINDENBACH, BRETT YALE UNIVERSITY CT $418,126
Hepatitis - C 2016 NCATS 5KL2TR001441-02 UTMB Clinical and Translational Science Award AMEREDES, BILL UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $423,432
Hepatitis - C 2016 NIMHD 1U01MD010614-01 Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities CARRASQUILLO, OLVEEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $514,693
Hepatitis - C 2016 NIAAA 4U01AA017347-10 Tracking HIV Infection and Alcohol Abuse CNS Comorbidity with Neuroimaging PFEFFERBAUM, ADOLF SRI INTERNATIONAL CA $1,136,537
Hepatitis - C 2016 NIDA 5R01DA016017-14 Acute Hepatitis C Infection in Young Injectors PAGE, KIMBERLY UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $1,373,874
Hepatitis - C 2016 NIDA 5K23DA039060-02 Adaptation and testing of a primary care HCV group medical treatment intervention NORTON, BRIANNA ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $184,393
Hepatitis - C 2016 NIDDK 4K24DK078772-10 Patient-Oriented Research on Hepatitis in Special Populations CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $160,354
Hepatitis - C 2016 NIDDK 5K23DK101827-02 Bacterial Translocation and the Intestinal Microbiome in Recurrent Disease Following Liver Transplantation VERNA, ELIZABETH COLUMBIA UNIVERSITY HEALTH SCIENCES NY $151,610
Hepatitis - C 2016 NIDDK 4R01DK099558-04 Molecular Prognostic Indicators in Liver Cirrhosis and Cancer HOSHIDA, YUJIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $683,136
Hepatitis - C 2016 NIAID 1R01AI120733-01A1 The Impact of HCV Infection on Bone Turnover, Density, and Strength BROWN, TODD JOHNS HOPKINS UNIVERSITY MD $789,268
Hepatitis - C 2016 NIDA 1R21DA041953-01 Modeling HCV/HIV transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs ALTICE, FREDERICK YALE UNIVERSITY CT $221,514
Hepatitis - C 2016 NIAID 1R43AI120483-01A1 Diagnosing Active Hepatitis C Virus Infection by Electrical Detection of Protein Biomarkers using a Nanopore Device MORIN, TREVOR TWO PORE GUYS, INC. CA $225,000
Hepatitis - C 2016 NIDDK 1R01DK109823-01 HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression TIEN, PHYLLIS NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $613,493
Hepatitis - C 2016 NIDDK 4R01DK098079-04 HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $589,282
Hepatitis - C 2016 NIDA 2R01DA033862-04A1 Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD HAVENS, JENNIFER UNIVERSITY OF KENTUCKY KY $558,014
Hepatitis - C 2016 NLM 5G13LM011888-02 Risks Unforeseen: Policy-making, Science and the Politics of Contaminated Blood TAYLOR, ROSEMARY TUFTS UNIVERSITY MEDFORD MA $47,489
Hepatitis - C 2016 NIDDK 5R01DK108370-02 HIV-Associated Macrophage Alterations and Progressive Liver Disease CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $325,000
Hepatitis - C 2016 NIDA 5R01DA040506-02 A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study) MATTHEWS, GAIL UNIVERSITY OF NEW SOUTH WALES AUSTRA $641,939
Hepatitis - C 2016 NIAID 1R01AI125416-01 Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle HORNER, STACY DUKE UNIVERSITY NC $517,789
Hepatitis - C 2016 NIAID 1R21AI126582-01 Structure-based HCV vaccine design FOUNG, STEVEN STANFORD UNIVERSITY CA $246,400
Hepatitis - C 2016 NIAID 1R21AI126304-01 Hepacivirus control by T cells and broadly active antibodies MEALEY, ROBERT WASHINGTON STATE UNIVERSITY WA $189,896
Hepatitis - C 2016 NICHD 1R21HD089457-01 A Phase 1 Pharmacokinetic Trial of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination in Pregnant Women with Chronic Hepatitis C Virus Infection CHAPPELL, CATHERINE MAGEE-WOMEN'S RES INST AND FOUNDATION PA $289,696
Hepatitis - C 2016 NIAID 1F32AI126660-01 RNA-Protein Interactions During Hepatitis C Virus Infection ADAMS, REBECCA YALE UNIVERSITY CT $54,294
Hepatitis - C 2016 NIAID 1F32AI126892-01 The role of epistatic networks in shaping adaptive landscapes ACEVEDO, ASHLEY ROCKEFELLER UNIVERSITY NY $54,294
Hepatitis - C 2016 NIAID 1F31AI126863-01 Host and viral determinants of hepatitis C virus species tropism GRAY, ESSANNA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $38,796
Hepatitis - C 2016 NIAID 1R01AI126890-01 T cell Immunity and the Outcome of Acute HCV Infection WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $797,768
Hepatitis - C 2016 NIDA 1K23DA041294-01A1 The impact of social networks on hepatitis C transmission and care access in people who inject drugs FALADE-NWULIA, OLUWASEUN JOHNS HOPKINS UNIVERSITY MD $183,748
Hepatitis - C 2016 NIAID 1K01AI122853-01A1 Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment Era MARCUS, JULIA KAISER FOUNDATION RESEARCH INSTITUTE CA $146,700
Hepatitis - C 2016 NIDDK 1R43DK109863-01A1 Rapid assay platform for POC Hepatitis C core antigen testing ARAZ, MUHAMMET CORRELIA BIOSYSTEMS, INC. CA $223,898
Hepatitis - C 2016 NIDA 1R01DA041501-01A1 The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $761,598
Hepatitis - C 2016 NIAAA 2U01AA020799-06 4/6 COMpAAAS U01: Operations Research Study BRAITHWAITE, RONALD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $198,972
Hepatitis - C 2016 NIAAA 2U24AA020794-06 1/6 COMpAAAS U24: Coordinating Center JUSTICE, AMY YALE UNIVERSITY CT $235,620
Hepatitis - C 2016 NIDA 1R21DA042727-01 Novel methods for research on young rural opioid users at risk of HIV, HCV & OD COOPER, HANNAH EMORY UNIVERSITY GA $244,437
Hepatitis - C 2016 NIAAA 2U01AA020790-06 2/6 COMpAAAS U01: Observation Study JUSTICE, AMY YALE UNIVERSITY CT $1,066,579
Hepatitis - C 2016 NIDA 7R01DA003574-32 Risk Factors for AIDS among Drug Users: Getting Close to Zero DES JARLAIS, DON ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $690,640
Hepatitis - C 2016 RMAP 1R03CA211210-01 A Multi-Omics Approach to Identify a Biomarker Panel for the Early Detection of Hepatocellular Carcinoma in Hepatitis C+ Individuals SPRATT, HEIDI UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $155,000
Hepatitis - C 2016 NIDA 1R01DA043130-01 A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,595,847
Hepatitis - C 2016 NIAID 1R01AI123136-01A1 Flavivirus non-coding RNAs and the Host mRNA Decay Machinery WILUSZ, JEFFREY COLORADO STATE UNIVERSITY CO $370,939
Hepatitis - C 2016 NIDA 3UG1DA015815-14S3 Western States Node of the National Drug Abuse Treatment Clinical Trials Network SORENSEN, JAMES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $224,441
Hepatitis - C 2016 NIDA 1R03DA043373-01 Identifying Ecologically Valid Intervention Opportunities to Reduce Opioid Injection Drug Use in Southwestern Pennsylvania BURKE, JESSICA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $91,750
Hepatitis - C 2016 NIDA 1R03DA043377-01 Improving Outcomes after Prison for Appalachian PWIO: The Role of XR-NTX & Networks OSER, CARRIE UNIVERSITY OF KENTUCKY KY $88,000
Hepatitis - C 2016 NIDA 1R03DA043379-01 Epidemiology of HCV Treatment Knowledge and Utilization among Opioid Injectors in Rural Appalachia HAVENS, JENNIFER UNIVERSITY OF KENTUCKY KY $86,422
Hepatitis - C 2016 NIDA 3R21DA038304-01A1S1 Digital Health Technology Use Among Methadone Maintenance Patients MASSON, CARMEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $11,593
Hepatitis - C 2016 NCI 3R21CA188472-02S1 Establishment of PDX mouse models and cell lines from hepatitis C virus associated liver cancer patients from CA and AA ethnic groups RAY, RATNA SAINT LOUIS UNIVERSITY MO $199,954
Hepatitis - C 2016 NIAID 3R01AI108765-03S1 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $39,438
Hepatitis - C 2016 NIAID 4R33AI116228-03 Targeting HIV-1 persistence with Interferon-a YU, XU MASSACHUSETTS GENERAL HOSPITAL MA $513,000
Hepatitis - C 2016 OD 3R01DA016017-14S1 Acute Hepatitis C Infection in Young Injectors PAGE, KIMBERLY UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $99,999
Hepatitis - C 2016 NIAID 272201400058C-4-0-1 Discovery and Characterization of B-Cell Epitopes for Hepatitis C Virus and Ebola Virus DORANZ, BENJAMIN INTEGRAL MOLECULAR PA $716,034
Hepatitis - C 2016 NIAID 1U01AI131313-01 T Cell Immunity and HCV Infection Outcome WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $276,574
Hepatitis - C 2016 NIAID 1U01AI131314-01 Immune Control and Evadion during Acute HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $276,000
Hepatitis - C 2016 NCI 1ZIACP005782-22 Epidemiology of Oncogenic Viruses O'BRIEN, THOMAS NIH $251,756
Hepatitis - C 2016 NCI 1ZIACP010127-21 Etiologic Studies of Diet and Cancer FREEDMAN, NEAL NIH $61,954
Hepatitis - C 2016 NCI 1ZIACP010158-16 Studies of Rare Cancers MCGLYNN, KATHERINE NIH $582,056
Hepatitis - C 2016 NIAID 1ZIAAI000361-34 International Studies Of Acquired Immune Deficiency Syndrome (AIDS) QUINN, THOMAS NIH $1,036,099
Hepatitis - C 2016 NHLBI AHL16005001-1-0-1 Temporal Trends in Transfusion –Transmissible Infections Risks and Monitoring of Donor Risk Factors in the US Blood Supply Project (TTIMS)-Non-AIDS NO PI IDENTIFIED NIH $363,153
Hepatitis - C 2016 NCI 1ZIABC005793-22 Mechanism of viral hepatitis-mediated hepatocarcinogenesis WANG, XIN NIH $111,437
Hepatitis - C 2016 NCI 1ZIABC011472-05 Isolation of antiviral proteins from natural product extracts OKEEFE, BARRY NIH $286,175
Hepatitis - C 2016 NIAID 1ZIAAI000999-10 Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases FARCI, PATRIZIA NIH $1,253,600
Hepatitis - C 2016 NIDDK 1ZIADK054503-20 Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C LIANG, T. NIH $1,060,516
Hepatitis - C 2016 NIDDK 1ZIADK054504-20 Studies of HCV Infection And HCV-Host interactions LIANG, T. NIH $1,060,516
Hepatitis - C 2016 NIDDK 1ZIADK054505-20 Mechanisms of Therapy and Model Development in Hepatitis C and Liver Diseases LIANG, T. NIH $848,413
Hepatitis - C 2016 NIDDK 1ZIADK054508-19 Analysis and Modulation of Virus-Host Interaction in Infections of the Liver REHERMANN, BARBARA NIH $795,677
Hepatitis - C 2016 NIDDK 1ZIADK054509-19 Immunology of Acute and Chronic Viral Hepatitis REHERMANN, BARBARA NIH $795,677
Hepatitis - C 2016 NIDDK 1ZIADK054511-10 The Genetics of Disease Progression and Treatment Response in Hepatitis C LIANG, T. NIH $212,103
Hepatitis - C 2016 NIDDK 1ZIADK054514-10 Investigation of management and disease manifestations of viral hepatitis HELLER, THEO NIH $612,410
Hepatitis - C 2016 NIDDK 1ZIADK054516-10 Role of the innate immune defenses in viral infections REHERMANN, BARBARA NIH $1,060,903
Hepatitis - C 2016 NIDDK 1ZIADK075009-11 Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C GHANY, MARC NIH $534,619
Hepatitis - C 2016 NIAID 272201200005I-0-27200020-1 Task X20:Master Cell Banks RICHARDSON, JAMES ADVANCED BIOSCIENCE LABORATORIES, INC. MD $463,269
Hepatitis - C 2016 NCATS 1ZIATR000177-02 Quantitative High Throughput Screen to Identify Novel Antivirals against Hepatitis C Virus in a Cell-Based Infection Assay SOUTHALL, NOEL NIH $121,984


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer